15 December 2022

Diagnostics PBS Rheumatoid Arthritis Ross River Virus Spondyloarthritis

Rheumatology Republic year in review

20 October 2022

COVID-19 PBS

Evusheld 300 stalls while leflunomide frees up

21 September 2022

PBAC

Deucravacitinib FDA approved for plaque psoriasis

22 August 2022

PBS Reactive Arthritis

Anifrolumab hits PBAC roadblock

12 May 2022

Medicare PBS Political Research Rural Telehealth

Rheums for improvement

28 April 2022

Biologics PBS

Regulatory review – March 2022 PBAC recommendations

26 April 2022

Lupus PBS Psoriatic Athritis Scleroderma Spondyloarthritis

PBS biologics approval shakeup on the way

24 February 2022

Biologics

Regulatory review – November 2021 PBAC recommendations

21 October 2021

Comment Corticosteroids

A red-letter day for rituximab

18 October 2021

Biologics Reactive Arthritis

Rituximab in line for open PBS listing without authority